Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis
{{output}}
Introduction: Adult secondary hemophagocytic lymphohistiocytosis (asHLH) is a fulminant hyperinflammatory condition triggered by cancers, infections, autoimmune conditions or drugs. The hallmark of its pathogenesis involves dysre... ...
